Sasha Cucuz
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
Mr. Sasha Cucuz is an Independent Director at NeuPath Health, Inc., a Chief Executive Officer at Greybrook Securities, Inc., an Executive Vice President at TMS NeuroHealth Centers Tysons Corner LLC and a Principal at Greybrook Health, Inc. He is on the Board of Directors at Neuronetics, Inc., NeuPath Health, Inc., Blu Genes Foundation, Delos Canada, Inc., Greysprings Apartments and The Greybrook Montreal-QC Value-Add Trust.
Mr. Cucuz was previously employed as a Chairman by Greenbrook TMS, Inc., a Principal by CIBC Capital Partners, a Founder by Greybrook Corp., a Principal by TD Securities, Inc., and a Director & Executive Vice President by TMS NeuroHealth Centers, Inc. He also served on the board at Klinik Health Ventures Corp.
He received his undergraduate degree from York University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEURONETICS, INC. 3,12 % | 28.05.2026 | 2 060 924 ( 3,12 % ) | 3 Mio $ | 31.05.2026 |
NEUPATH HEALTH INC. 0,17 % | 15.06.2026 | 93 118 ( 0,17 % ) | 39 855 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUPATH HEALTH INC. | Direktor/Vorstandsmitglied | 25.06.2020 |
| NEURONETICS, INC. | Direktor/Vorstandsmitglied | 10.12.2024 |
Greybrook Health, Inc.
Greybrook Health, Inc. Investment ManagersFinance Greybrook Healthcare is an active manager which invests in companies located in Canada. The firm targets companies operating in the fields of medical device and healthcare services companies. It provides financing for growth stage capital requirements. | Private Equity Investor | - |
TMS NeuroHealth Centers Tysons Corner LLC
TMS NeuroHealth Centers Tysons Corner LLC Medical/Nursing ServicesHealth Services Provides treatment for depressive disorder and other neurological diseases | Gründer | 01.01.2011 |
Greybrook Securities, Inc. | Vorstandsvorsitzender | 01.01.2005 |
Blu Genes Foundation
Blu Genes Foundation Miscellaneous Commercial ServicesCommercial Services Blu Genes Foundation is a charitable organization dedicated to advancing gene therapy research aimed at finding cures for rare and ultra-rare genetic disorders, including Tay-Sachs disease, hereditary spastic paraplegia type 4 (SPG4), and Pelizaeus-Merzbacher-like disease (PMLD). The private company is based in Toronto, Canada. The foundation raises funds to support research collaborations with institutions such as SickKids Hospital, University of Massachusetts, Cyprus Institute of Neurology and Genetics, Children’s Hospital, and Drexel University. Key initiatives include funding CRISPR/Cas9 genome editing studies to correct Tay-Sachs mutations, developing AAV-mediated gene therapies for SPG4, and innovative approaches to overcome delivery challenges for PMLD treatments. The foundation directs all donations to research efforts and provides transparency through annual impact reports, news updates, and community engagement events, while supporting affected families and fostering public awareness of rare genetic disorders. | Direktor/Vorstandsmitglied | - |
The Greybrook Montreal-QC Value-Add Trust
The Greybrook Montreal-QC Value-Add Trust Real Estate DevelopmentFinance Provides real estate services | Direktor/Vorstandsmitglied | - |
Delos Canada | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| GREENBROOK TMS INC. | Vorsitzender | 09.12.2024 |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
Neuronetics, Inc.
Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
TMS NeuroHealth Centers Tysons Corner LLC
TMS NeuroHealth Centers Tysons Corner LLC Medical/Nursing ServicesHealth Services Provides treatment for depressive disorder and other neurological diseases | Health Services |
TD Securities, Inc.
TD Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
York University
York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CIBC Capital Partners
CIBC Capital Partners Investment ManagersFinance Alternative investment manager | Finance |
Greybrook Health, Inc.
Greybrook Health, Inc. Investment ManagersFinance Greybrook Healthcare is an active manager which invests in companies located in Canada. The firm targets companies operating in the fields of medical device and healthcare services companies. It provides financing for growth stage capital requirements. | Finance |
TMS NeuroHealth Centers, Inc.
TMS NeuroHealth Centers, Inc. Medical/Nursing ServicesHealth Services Provides depressive disorder treatments | Health Services |
Greybrook Corp.
Greybrook Corp. Investment ManagersFinance Provides real estate investment and asset management services | Finance |
Greenbrook TMS, Inc.
Greenbrook TMS, Inc. Medical/Nursing ServicesHealth Services Provides transcranial magnetic stimulation therapy services for treatment of major depressive and mental health disorders | Health Services |
Greybrook Securities, Inc. | |
The Greybrook Montreal-QC Value-Add Trust
The Greybrook Montreal-QC Value-Add Trust Real Estate DevelopmentFinance Provides real estate services | Finance |
Blu Genes Foundation
Blu Genes Foundation Miscellaneous Commercial ServicesCommercial Services Blu Genes Foundation is a charitable organization dedicated to advancing gene therapy research aimed at finding cures for rare and ultra-rare genetic disorders, including Tay-Sachs disease, hereditary spastic paraplegia type 4 (SPG4), and Pelizaeus-Merzbacher-like disease (PMLD). The private company is based in Toronto, Canada. The foundation raises funds to support research collaborations with institutions such as SickKids Hospital, University of Massachusetts, Cyprus Institute of Neurology and Genetics, Children’s Hospital, and Drexel University. Key initiatives include funding CRISPR/Cas9 genome editing studies to correct Tay-Sachs mutations, developing AAV-mediated gene therapies for SPG4, and innovative approaches to overcome delivery challenges for PMLD treatments. The foundation directs all donations to research efforts and provides transparency through annual impact reports, news updates, and community engagement events, while supporting affected families and fostering public awareness of rare genetic disorders. | Commercial Services |
Klinik Health Ventures Corp.
Klinik Health Ventures Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NeuPath Health, Inc.
NeuPath Health, Inc. Financial ConglomeratesFinance Provides chronic pain management services | Finance |
Delos Canada |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen